ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ALIM Alimera Sciences Inc

5.54
0.00 (0.00%)
22 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Alimera Sciences Inc NASDAQ:ALIM NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 5.54 5.07 5.58 0 00:00:00

Form 15-12G - Securities registration termination [Section 12(g)]

26/09/2024 9:55pm

Edgar (US Regulatory)



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 


FORM 15



CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
 
Commission File Number: 001-34703


 
Alimera Sciences, Inc.
(Exact name of registrant as specified in its charter)


6310 Town Square, Suite 400
Alpharetta, GA 30005
(678) 990-5740
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, $0.01 par value per share
(Title of each class of securities covered by this Form)
 
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)
Rule 12g-4(a)(2)
Rule 12h-3(b)(1)(i)
Rule 12h-3(b)(1)(ii)
Rule 15d-6
Rule 15d-22(b)
 
Approximate number of holders of record as of the certification or notice date: One (1)



Pursuant to the requirements of the Securities Exchange Act of 1934, Alimera Sciences, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date: September 26, 2024
 
 
ALIMERA SCIENCES, INC.
   
 
By:
/s/ Stephen P. Carey
 
Name:
Stephen P. Carey
 
Title:
Director and Chief Financial Officer




1 Year Alimera Sciences Chart

1 Year Alimera Sciences Chart

1 Month Alimera Sciences Chart

1 Month Alimera Sciences Chart

Your Recent History

Delayed Upgrade Clock